Phase 1 Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Solid Tumors
Condition(s):Metastatic Adenocarcinoma of the Colon or Rectum; Malignant Solid TumorsLast Updated:May 5, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Metastatic Adenocarcinoma of the Colon or Rectum; Malignant Solid TumorsLast Updated:May 5, 2021Completed
Condition(s):Colorectal Cancer; Diet HabitLast Updated:March 19, 2024Recruiting
Condition(s):Colorectal CancerLast Updated:October 25, 2022Completed
Condition(s):Metastatic Colorectal CancerLast Updated:July 26, 2022Completed
Condition(s):Microscopic Colitis; Colorectal Cancer; Colon AdenomaLast Updated:December 15, 2023Recruiting
Condition(s):Breast Neoplasms; Colonic Neoplasms; Rectal NeoplasmsLast Updated:December 14, 2022Completed
Condition(s):Acute Malignant Colonic Obstruction; Colorectal Cancer; Colonic ObstructionLast Updated:November 20, 2015Unknown status
Condition(s):Epithelial Ovarian Cancer; Rectosigmoid Cancer MetastaticLast Updated:February 9, 2023Recruiting
Condition(s):Breast Cancer; Colorectal Cancer; Cancer of Ovary; Cancer of EndometriumLast Updated:February 8, 2023Recruiting
Condition(s):Neoplasms,ColorectalLast Updated:December 9, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.